Guardant Health Inc header image

Guardant Health Inc

GH

Equity

ISIN null / Valor 43633454

NASDAQ (2026-10-09)
USD 167.47+1.15%

Guardant Health Inc
UMushroom community rating:

star star star star star
4.29 7 votes No rating yet
NegativeNeutralPositive

About company

Guardant Health Inc is a company that focuses on utilizing blood tests to provide valuable insights for improving clinical outcomes in cancer care. With over 500,000 tests performed by 12,000 doctors, their commercially available tests assist in treatment decisions for advanced cancer patients, monitoring treatment response, detecting residual and recurrent disease in early-stage cancer patients, and potentially screening for cancer before symptoms appear. Additionally, their products support pharmaceutical companies in developing innovative cancer therapies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

157%1Y
496%3Y
60.5%5Y

Performance

56.7%1Y
63.3%3Y
69.3%5Y

Volatility

Market cap

22474 M

Market cap (USD)

Daily traded volume (Shares)

1,520,098

Daily traded volume (Shares)

1 day high/low

31.2 / 29.98

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.29

7 votes
Performance:
starstarstarstarstar
4.43
Innovation:
starstarstarstarstar
4.57
Society:
starstarstarstarstar
4.57
Nature:
starstarstarstarstar
4.14
Luba Schoenig
Switzerland, 01 Nov 2022
star star star star star
Admin UMushroom
Switzerland, 01 Nov 2022
star star star star star
Laura Bischofberger
Switzerland, 01 Nov 2022
star star star star star
Promissing news release regarding fight cancer.

EQUITIES OF THE SAME SECTOR

CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 63.82
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.18%USD 19.45
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.69%SEK 263.70
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 65.35
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%USD 7.67
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.38%USD 70.93
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.58%USD 37.19
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 34.43
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%USD 26.51
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 26.50